CMV pneumonia is a major cause of morbidity and mortality among allogeneic BMT recipients. To assess the frequency, timing, risk factors and response to therapy of CMV pneumonia among autologous ...

The incidence, treatment and outcome of CMV interstitial pneumonia (CMV-IP) were reviewed in 139 consecutive allogeneic BMT patients undergoing extended CMV antigenemia surveillance and two ...

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

Antiviral and Immunoglobulin Therapy for CMV in Liver Transplantation. ... CMV pneumonia, or invasive fungal infection in association with CMV disease), ...

Patient 2: A previously healthy 30-year-old man developed p. carinii pneumonia in April 1981 after a 5-month history of fever each day and of elevated liver-function tests, CMV viruria, and ...

A CMV infection is particularly devastating for a fetus, and can cause issues such as cerebral palsy, seizures, ... a months-old infant who had developed pneumonia.

Ten patients being treated for suspected pulmonary aspergillosis, 7 patients treated for suspected pulmonary cytomegalovirus infection, 22 patients treated for suspected bacterial pneumonia, 2 ...

Orlando- In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital ...

CMV infection of the fetus causes birth defects, and in immunocompromised patients, CMV infection of the lung can result in life-threatening pneumonia.

Symptoms in infants are more severe and include low birth weight, jaundice, poor liver function, pneumonia. → Common tre ... CMV infection goes undiagnosed as it does not show any symptoms. ...